This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the results of Neurocrine's CAHtalyst study with crinecerfont in Congenital adrenal hyperplasia

Ticker(s): NBIX

Who's the expert?

Institution: Karolinska University Hospital

  • Associate Professor of Endocrinology at Karolinska University Hospital, Stockholm, Sweden & Director of the Adrenal Unit at Department of Endocrinology.
  • Research focuses on Congenital adrenal hyperplasia (249 peer reviewed publications, h-index of 41, half of the publications deal with CAH)
  • PI on several academic and industrial sponsored studies.

Interview Questions
Q1.

Roughly how many CAH patients do you treat?

Added By: wilson_admin
Q2.

How are CAH patients currently treated?

Added By: wilson_admin
Q3.

How enthusiastic are you over crinecerfont? 

Added By: wilson_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.